Temmune Therapeutics
Board
4 directors, 1 in day-to-day management, 1 auditor, no change since February 2026Director
since 23-09-2024
term until the 2030 general meeting
listed in the 2025 annual accounts, filed on 07-04-2026
Director
since 23-09-2024
term until the 2030 general meeting
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 07-04-2026
Heyman Tomas
Director
since 18-12-2025
term until 18-12-2031
listed in the 2025 annual accounts, filed on 07-04-2026
Director, permanent representative WILMS Tobias
since 18-12-2025
term until 18-12-2031
also on the board of 74 other companies
listed in the 2025 annual accounts, filed on 07-04-2026
5 other companies bankrupt, 1 judicially dissolvedLIFE of SCI BV
Director, permanent representative Joris De Maeyer
appointed by deed of 30-06-2025
6-year term from 2026
also on the board of 1 other company
Statutory auditor, permanent representative Gert Maris
current term since 14-03-2025
term until 12-03-2027
listed in the 2025 annual accounts, filed on 07-04-2026
- LIFE of SCI
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Er wordt herinnerd dat de Vennootschap overeenkomstig haar statuten geldig vertegenwoordigd wordt als volgt: "De raad van bestuur…”deed of 20-03-2026
Permanent representatives 2
WILMS Tobias
Permanent representative, for Participatiemaatschappij Vlaanderen
appointed by deed of 02-01-2026
Mandates through the years
11 names, the dashed line is todayMcCullagh Keith Graham
Director
Director
Roderick Verhelst
Director
Director
Heyman Tomas
Director
Director
LIFE of SCI
Day-to-day manager
Day-to-day manager
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Statutory auditor
Statutory auditor
Tom Heyman
Day-to-day manager
Day-to-day manager
REYN Dirk
Director
Director
LIGHTFOOT Andrew Philip
Director
Director
Groovy.Bio
Director
Director
LeadershipBoardOther functionEarlierRest of the termmandate already running before its first mention
Mandates as a list
- McCullagh Keith Graham
- Director, from 23-09-2024 to date
- Roderick Verhelst
- Director, from 23-09-2024 to date
- Heyman Tomas
- Director, since before 31-12-2024
- Participatiemaatschappij Vlaanderen
- Director, from 18-12-2025 to date
- LIFE of SCI
- Day-to-day manager, appointed by deed of 30-06-2025, still in office
- BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
- Statutory auditor, appointed by deed of 30-09-2024, still in office
- Bioqube Factory Project Company CommV
- Director, from 29-10-2021 to date
- Tom Heyman
- Director, appointed by deed of 30-06-2025, until 02-01-2026
- Day-to-day manager, appointed by deed of 30-06-2025, until 09-02-2026
- REYN Dirk
- Director, appointed by deed of 30-09-2024, until 02-01-2026
- LIGHTFOOT Andrew Philip
- Director, appointed by deed of 30-09-2024, until 01-04-2025
- Groovy.Bio
- Director, until 23-09-2024
Control
60.43%
This company
Temmune Therapeutics
Equity €2.0m
Loss €2.2m in 2025
Capital
- Capital
- €4,347,047.79
- Shares
- 400,000 in the deed of 10-11-2021
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- BIOQUBE FACTORY FUND I
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 30-01-2025 (in Dutch)
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- 400,000 sharesdeed of 10-11-2021 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of March at 09:00deed of 30-01-2025 (in Dutch)
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Ontbinding op elk ogenblik door besluit algemene vergadering in vorm en wijze voor statutenwijziging”deed of 30-01-2025 (in Dutch)
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Algemene vergadering kan bevoegdheden te allen tijde bij gewone meerderheid beperken, benoeming desgevallend ter bevestiging aan voorzitter…”deed of 30-01-2025 (in Dutch)
Shareholders
2 ownersOwners 2
- BIOQUBE FACTORY FUND IparentEquity €67.0m Loss of €1.1m in 2025 (loss of €1.8m in 2024) Checked score 9660.43%
- Equity €544,484 Loss of €297,520 in 2025 (loss of €343,512 in 2024) Checked score 57Sourcedeed 30-09-2024share not stated
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 30-09-2024 ↗
- Bioqube Factory Fund I Comm.V (BE 0747.784.678) 1,700,000 shares
- Bioqube Factory Project Company (BE 0776.937.633) 1 share
At incorporation
deed of 10-11-2021 ↗
- Bioqube Factory Project Company CommV gecommanditeerde vennoot · 1 share (0%) · €1
- Bioqube Factory Fund I CommV (BE 0747.784.678) 399,999 shares (100%) · €399,999
Capital over time
- 30-01-2025 Capital increase of €2,000,000.80 · to €4,980,601.46 · 1,503,760 new shares at €1.33 per share · in cash
- 30-01-2025 Capital reduction of €633,553.67 · to €4,347,047.79 · “ter aanzuivering van geleden verliezen”
- 30-09-2024 Capital increase of €1,940,000 · 1,940,000 new shares · in kind
- 30-09-2024 Capital increase of €1,000,000 · 1,000,000 new shares · in cash
- 30-09-2024 Capital reduction of €1,660,744.42
- 10-11-2021 Incorporation · €400,000 · 400,000 shares
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off5 other companies of this director went bankrupt (2022, 2023, 2025, 2026) and 1 was judicially dissolved (2025).
- QOLLABI bankruptcy on 07-05-2026Official Gazetteappointed in 2022, still in office
- REIN4CED bankruptcy on 29-12-2025Official Gazetteappointed in 2022, still in office
- OXYPOINT bankruptcy on 11-12-2025Official Gazettemandate 2020 to 2022
- OTRA SOLUTIONS judicial dissolution on 20-11-2025Official Gazetteappointed in 2021, still in office
- VILOC bankruptcy on 26-01-2023Official Gazettemandate until 2022
- LindaCare bankruptcy on 02-06-2022Official Gazetteappointed in 2018, still in office
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.